Squalene Market - Global Forecast 2025-2032

The squalene market is transitioning as sustainability, regulatory drivers, and advanced technologies push producers toward innovative, ethical business models. Senior leaders are increasingly focused on aligning sourcing, product development, and compliance to these evolving sector standards.

Market Snapshot: Squalene Market Growth and Outlook

The squalene market grew from USD 161.06 million in 2024 to USD 173.47 million in 2025, with a projected compound annual growth rate (CAGR) of 7.76%, reaching USD 292.90 million by 2032. Expansion is fueled by surging adoption across cosmetics, nutraceuticals, and pharmaceuticals. Stakeholders are responding to stronger clean-label preferences, high sustainability standards, and the rapid adoption of biotechnological manufacturing. Increased attention to compliance and shifting consumer attitudes toward sourcing are catalyzing agility and innovation across product pipelines and procurement networks.

Scope & Segmentation: Squalene Market Coverage

• Source: Squalene supply comes from plant-based feedstocks like olive oil, palm oil, and sugarcane, marine-derived shark liver oil, and synthetic sources via microbial fermentation. Plant and bio-based sources are seeing stronger momentum, as regulations and ethical demands push stakeholder decisions.
• Application: Key uses span cosmetics and personal care—including haircare, makeup, and skincare—plus food and beverage (fortified foods, functional drinks), nutraceuticals such as dietary supplements and sports nutrition, and pharmaceutical applications for antioxidant therapy and drug delivery. The health and wellness sector is a consistent growth driver.
• Form: Available as both liquid and powder, squalene offers manufacturers flexibility to serve a broad range of product formulations meeting diverse functional needs.
• Purity Grade: Coverage includes analytical, cosmetic, food, and pharmaceutical grade squalene, ensuring compatibility with sector-specific requirements and quality regimes.
• Distribution Channel: Access provided through offline retail (pharmacies, specialty stores, drugstores) and online platforms, including brand websites and leading e-commerce channels. Online distribution continues to expand market accessibility and global market reach.
• Regional Coverage: The Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East and Africa (including UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan). Regional variations in biotechnology investment, market demand, and supply scenarios drive differentiated growth strategies.
• Leading Companies: Major entities active in the market include Croda International Plc, Evonik Industries AG, BASF SE, Givaudan SA, SEPPIC SA, Koninklijke DSM N.V., Lonza Group AG, Amyris, Inc., Sophim SA, and Greentech SAS.

Key Takeaways for Senior Decision-Makers

• Shifts in consumer preferences toward ethical and vegan solutions are accelerating the move away from marine-sourced squalene, strengthening opportunities for producers of plant-derived and synthetic variants.
• Technology enhancements in extraction and refining are key to producing higher-quality squalene, opening new possibilities for product innovation and strengthening compliance with evolving market standards.
• Strategic partnerships and greater investments in biotechnology are bolstering supply-chain resilience and enabling entry into emerging application fields, critical in response to market volatility and new technologies.
• Digital traceability, utilizing blockchain and comprehensive auditing, is helping companies build transparency, manage complex regulatory environments, and increase stakeholder trust regarding sourcing and supply-chain integrity.
• Distinct regional trends—such as clean beauty momentum in North America and sustained biotechnology growth in Asia-Pacific—present actionable opportunities for regional strategy customization and market engagement.

Tariff Impact: United States Trade Policy

Starting in 2025, updated U.S. tariffs are expected to alter import cost equations, particularly affecting plant-based squalene and derived products. Companies may adapt by adjusting procurement tactics, prioritizing domestic biomanufacturing, or favoring fermentation-sourced squalene to offset tariff impacts. Value chain collaboration and integrated planning are set to gain importance for organizations seeking supply stability and pricing certainty amid regulatory and trade adjustments.

Methodology & Data Sources

This report leverages a combined approach of in-depth primary interviews with industry stakeholders—including producers, regulators, and end users—alongside comprehensive secondary research sourced from scholarly studies, patent filings, legal documents, and corporate reports. Forecasts are grounded in scenario modeling and stringent data validation processes.

Why This Report Matters

• Provides market intelligence enabling robust sourcing, risk management, and production planning within a changing regulatory landscape.
• Highlights practical use of biotechnology and digital traceability to advance sustainability and regulatory best practices in the squalene market.
• Supports strategic decision-making for entry or expansion by clarifying application trends, regional variations, and evolving technology adoption.

Conclusion

The squalene market is evolving, led by shifts in feedstock sourcing, technology innovation, and compliance priorities. This report gives decision-makers the perspective needed for confident, forward-looking strategies in a dynamic sector.